Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

scientific article

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2006.09.0928
P698PubMed publication ID17470860

P50authorAlfredo FalconeQ51195550
P2093author name stringEnrico Cortesi
Cinzia Orlandini
Sergio Ricci
Lucio Crinò
Luisa Fioretto
Gianluca Masi
Cristina Granetto
Silvana Chiara
Michele Andreuccetti
Giovanni Benedetti
Cecilia Barbara
Elisabetta Pfanner
Giacomo Allegrini
Gianfranco Porcile
Laura Fanchini
Stefano Vitello
Vincenzo Picone
Walter Evangelista
Gruppo Oncologico Nord Ovest
Isa Brunetti
P433issue13
P407language of work or nameEnglishQ1860
P921main subjectirinotecanQ412197
oxaliplatinQ422327
colorectal cancerQ188874
fluorouracilQ238512
colorectal carcinomaQ25493920
phase III clinical trialQ42824827
metastatic colon cancerQ108566365
P304page(s)1670-1676
P577publication date2007-05-01
P1433published inJournal of Clinical OncologyQ400292
P1476titlePhase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest
P478volume25